Cargando…
Osteonecrosis of the jaw (ONJ) in patients who receive Bone Targeting Agents (BTAs): the power of e-learning
The definition, pathobiology and risk factors of ONJ in cancer patients who receive BTAs are discussed in the recent ecancer module for osteonecrosis of the jaw (http://ecancer.org/education/module/276-osteonecrosis-of-the-jaw.php). ONJ prevention, early diagnosis and management are presented. The c...
Autores principales: | Nicolatou-Galitis, Ourania, Migliorati, Cesar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813916/ https://www.ncbi.nlm.nih.gov/pubmed/29456623 http://dx.doi.org/10.3332/ecancer.2018.ed77 |
Ejemplares similares
-
Osteonecrosis of the Jaws (ONJ) after Bisphosphonate Treatment in Patients with Multiple Myeloma: Decreasing ONJ Incidence after Adoption of Preventive Measures
por: Catania, Gioacchino, et al.
Publicado: (2016) -
Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors
por: Wan, Jason T., et al.
Publicado: (2020) -
Osteonecrosis of the Jaw (ONJ) in Osteoporosis Patients: Report of Delayed Diagnosis of a Multisite Case and Commentary about Risks Coming from a Restricted ONJ Definition
por: Migliario, Mario, et al.
Publicado: (2017) -
A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer
por: Schiodt, Morten, et al.
Publicado: (2017) -
Delayed Diagnosis of Osteonecrosis of the Jaw (ONJ) Associated with Bevacizumab Therapy in Colorectal Cancer Patients: Report of Two Cases
por: Erovigni, Francesco, et al.
Publicado: (2016)